BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20718073)

  • 1. Synthesis and antiplasmodial activity of highly active reverse analogues of the antimalarial drug candidate fosmidomycin.
    Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Gräwert T; Groll M; Rohdich F; Bacher A; Eisenreich W; Fischer M; Maes L; Kurz T
    ChemMedChem; 2010 Oct; 5(10):1673-6. PubMed ID: 20718073
    [No Abstract]   [Full Text] [Related]  

  • 2. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
    Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
    J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of phosphonated N-heteroarylcarboxamides as DOXP-reductoisomerase (DXR) inhibitors.
    Bodill T; Conibear AC; Blatch GL; Lobb KA; Kaye PT
    Bioorg Med Chem; 2011 Feb; 19(3):1321-7. PubMed ID: 21216609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
    Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of cyclopropyl analogues of fosmidomycin as potent Plasmodium falciparum growth inhibitors.
    Devreux V; Wiesner J; Goeman JL; Van der Eycken J; Jomaa H; Van Calenbergh S
    J Med Chem; 2006 Apr; 49(8):2656-60. PubMed ID: 16610809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DXR inhibition by potent mono- and disubstituted fosmidomycin analogues.
    Jansson AM; Więckowska A; Björkelid C; Yahiaoui S; Sooriyaarachchi S; Lindh M; Bergfors T; Dharavath S; Desroses M; Suresh S; Andaloussi M; Nikhil R; Sreevalli S; Srinivasa BR; Larhed M; Jones TA; Karlén A; Mowbray SL
    J Med Chem; 2013 Aug; 56(15):6190-9. PubMed ID: 23819803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planting the seeds of new antimalarial drugs.
    Ridley RG
    Science; 1999 Sep; 285(5433):1502-3. PubMed ID: 10498534
    [No Abstract]   [Full Text] [Related]  

  • 8. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
    Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
    Andaloussi M; Lindh M; Björkelid C; Suresh S; Wieckowska A; Iyer H; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5403-7. PubMed ID: 21824775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Substituted β-oxa isosteres of fosmidomycin: synthesis and biological evaluation.
    Brücher K; Illarionov B; Held J; Tschan S; Kunfermann A; Pein MK; Bacher A; Gräwert T; Maes L; Mordmüller B; Fischer M; Kurz T
    J Med Chem; 2012 Jul; 55(14):6566-75. PubMed ID: 22731758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
    Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
    Proteau PJ
    Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
    Perruchon J; Ortmann R; Altenkämper M; Silber K; Wiesner J; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1232-41. PubMed ID: 18470849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse
    Abdullaziz MA; Takada S; Illarionov B; Pessanha de Carvalho L; Sakamoto Y; Höfmann S; Knak T; Kiffe-Delf AL; Mazzone F; Pfeffer K; Kalscheuer R; Bacher A; Held J; Fischer M; Tanaka N; Kurz T
    ACS Infect Dis; 2024 May; 10(5):1739-1752. PubMed ID: 38647213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
    Giessmann D; Heidler P; Haemers T; Van Calenbergh S; Reichenberg A; Jomaa H; Weidemeyer C; Sanderbrand S; Wiesner J; Link A
    Chem Biodivers; 2008 Apr; 5(4):643-56. PubMed ID: 18421757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Woo YH; Fernandes RP; Proteau PJ
    Bioorg Med Chem; 2006 Apr; 14(7):2375-85. PubMed ID: 16310360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Mercklé L; de Andrés-Gómez A; Dick B; Cox RJ; Godfrey CR
    Chembiochem; 2005 Oct; 6(10):1866-74. PubMed ID: 16116659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.
    Jomaa H; Wiesner J; Sanderbrand S; Altincicek B; Weidemeyer C; Hintz M; Türbachova I; Eberl M; Zeidler J; Lichtenthaler HK; Soldati D; Beck E
    Science; 1999 Sep; 285(5433):1573-6. PubMed ID: 10477522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.
    Kuntz L; Tritsch D; Grosdemange-Billiard C; Hemmerlin A; Willem A; Bach TJ; Rohmer M
    Biochem J; 2005 Feb; 386(Pt 1):127-35. PubMed ID: 15473867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.
    Mac Sweeney A; Lange R; Fernandes RP; Schulz H; Dale GE; Douangamath A; Proteau PJ; Oefner C
    J Mol Biol; 2005 Jan; 345(1):115-27. PubMed ID: 15567415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.